These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30143364)

  • 1. Cognitive impairment predicts mortality in outpatient veterans with heart failure.
    Lan H; Hawkins LA; Kashner M; Perez E; Firek CJ; Silvet H
    Heart Lung; 2018 Nov; 47(6):546-552. PubMed ID: 30143364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions.
    Bavishi C; Ather S; Bambhroliya A; Jneid H; Virani SS; Bozkurt B; Deswal A
    Am J Cardiol; 2014 Jun; 113(11):1834-8. PubMed ID: 24837261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment and medication adherence in outpatients with heart failure.
    Hawkins LA; Kilian S; Firek A; Kashner TM; Firek CJ; Silvet H
    Heart Lung; 2012; 41(6):572-82. PubMed ID: 22784869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
    Cherian TS; Shrader P; Fonarow GC; Allen LA; Piccini JP; Peterson ED; Thomas L; Kowey PR; Gersh BJ; Mahaffey KW
    Am J Cardiol; 2017 Jun; 119(11):1763-1769. PubMed ID: 28416199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise duration and peak systolic blood pressure are predictive of mortality in ambulatory patients with mild-moderate chronic heart failure.
    Williams SG; Jackson M; Ng LL; Barker D; Patwala A; Tan LB
    Cardiology; 2005; 104(4):221-6. PubMed ID: 16158008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial.
    Ambrosy AP; Vaduganathan M; Mentz RJ; Greene SJ; Subačius H; Konstam MA; Maggioni AP; Swedberg K; Gheorghiade M
    Am Heart J; 2013 Feb; 165(2):216-25. PubMed ID: 23351825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IVC diameter in patients with chronic heart failure: relationships and prognostic significance.
    Pellicori P; Carubelli V; Zhang J; Castiello T; Sherwi N; Clark AL; Cleland JG
    JACC Cardiovasc Imaging; 2013 Jan; 6(1):16-28. PubMed ID: 23328557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure reactivity to psychological stress is associated with clinical outcomes in patients with heart failure.
    Sherwood A; Hill LK; Blumenthal JA; Adams KF; Paine NJ; Koch GG; O'Connor CM; Johnson KS; Hinderliter AL
    Am Heart J; 2017 Sep; 191():82-90. PubMed ID: 28888274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms underlying increased mortality risk in patients with heart failure and reduced ejection fraction randomly assigned to adaptive servoventilation in the SERVE-HF study: results of a secondary multistate modelling analysis.
    Eulenburg C; Wegscheider K; Woehrle H; Angermann C; d'Ortho MP; Erdmann E; Levy P; Simonds AK; Somers VK; Zannad F; Teschler H; Cowie MR
    Lancet Respir Med; 2016 Nov; 4(11):873-881. PubMed ID: 27592224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I-PRESERVE) trial.
    Cannon JA; Shen L; Jhund PS; Anand IS; Komajda M; McKelvie RS; Zile MR; Carson PE; McMurray JJ
    Eur J Heart Fail; 2016 Aug; 18(8):1021-31. PubMed ID: 27194023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
    Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
    JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy.
    Gronda E; Genovese S; Padeletti L; Cacciatore F; Vitale DF; Bragato R; Innocenti L; Schiano C; Sommese L; De Pascale MR; Genovese L; Abete P; Donatelli F; Napoli C
    Cardiol J; 2015; 22(4):459-66. PubMed ID: 26325259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure.
    Nakata T; Nakajima K; Yamashina S; Yamada T; Momose M; Kasama S; Matsui T; Matsuo S; Travin MI; Jacobson AF
    JACC Cardiovasc Imaging; 2013 Jul; 6(7):772-84. PubMed ID: 23845574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative Importance of History of Heart Failure Hospitalization and N-Terminal Pro-B-Type Natriuretic Peptide Level as Predictors of Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
    Kristensen SL; Jhund PS; Køber L; McKelvie RS; Zile MR; Anand IS; Komajda M; Cleland JGF; Carson PE; McMurray JJV
    JACC Heart Fail; 2015 Jun; 3(6):478-486. PubMed ID: 26046842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hopelessness and cognitive impairment are risk markers for mortality in systolic heart failure patients.
    Byrne CJ; Toukhsati SR; Toia D; O'Halloran PD; Hare DL
    J Psychosom Res; 2018 Jun; 109():12-18. PubMed ID: 29773147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right ventricular function in heart failure with preserved ejection fraction: a community-based study.
    Mohammed SF; Hussain I; AbouEzzeddine OF; Takahama H; Kwon SH; Forfia P; Roger VL; Redfield MM
    Circulation; 2014 Dec; 130(25):2310-20. PubMed ID: 25391518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-type natriuretic peptide levels in obese patients with advanced heart failure.
    Horwich TB; Hamilton MA; Fonarow GC
    J Am Coll Cardiol; 2006 Jan; 47(1):85-90. PubMed ID: 16386669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Veterans Affairs Saint Louis University mental status exam (SLUMS exam) and the Mini-mental status exam as predictors of mortality and institutionalization.
    Cruz-Oliver DM; Malmstrom TK; Allen CM; Tumosa N; Morley JE
    J Nutr Health Aging; 2012 Jul; 16(7):636-41. PubMed ID: 22836706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population.
    Chen LJ; Hung CL; Yeh HI; Jeng MJ; Su CH; Wu TY; Shih SC; Tsai CH
    BMC Cardiovasc Disord; 2016 Sep; 16(1):178. PubMed ID: 27613439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairments in chronic heart failure: a case controlled study.
    Sauvé MJ; Lewis WR; Blankenbiller M; Rickabaugh B; Pressler SJ
    J Card Fail; 2009 Feb; 15(1):1-10. PubMed ID: 19181287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.